Home Bifunctional epitope-agonist ligands of the bradykinin B2 receptor
Article
Licensed
Unlicensed Requires Authentication

Bifunctional epitope-agonist ligands of the bradykinin B2 receptor

  • Lajos Gera , Caroline Roy and François Marceau EMAIL logo
Published/Copyright: February 2, 2013

Abstract

Two bradykinin (BK) B2 receptor agonists N-terminally extended with the myc epitope were synthesized and evaluated: myc-KPG-BK and myc-KGP-B-9972. The latter was modeled on the inactivation-resistant agonist B-9972 (D-Arg0, Hyp3, Igl5, Oic7, Igl8-BK) and is also resistant to endosomal inactivation. Despite a large loss of affinity relative to the parent peptide, the tagged analogs are conventional agonists in the umbilical vein contractility assay and compete for [3H]BK binding at the rabbit B2 receptor. Endocytosed myc-KGP-B-9972 most effectively carried AlexaFluor-488-conjugated anti-myc monoclonal antibodies into intact cells expressing the B2 receptor. Results support the prospects of functionally-active cargoes entering cells in a pharmacologically controlled manner.


Corresponding author: François Marceau, Centre de recherche en rhumatologie et immunologie, Centre Hospitalier Universitaire de Québec, 2705 Laurier Blvd., Québec G1V 4G2, QC, Canada

Received: 2012-9-14
Accepted: 2012-12-8
Published Online: 2013-02-02
Published in Print: 2013-03-01

©2013 by Walter de Gruyter Berlin Boston

Downloaded on 18.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/hsz-2012-0286/html
Scroll to top button